Sio Capital Management as of Dec. 31, 2021
Portfolio Holdings for Sio Capital Management
Sio Capital Management holds 69 positions in its portfolio as reported in the December 2021 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Cigna Corp (CI) | 8.4 | $28M | 121k | 229.63 | |
Medicus Sciences Acquisition Cl A Shs | 6.8 | $23M | 2.3M | 9.72 | |
Curis Com New | 5.8 | $19M | 4.0M | 4.76 | |
Merck & Co (MRK) | 5.4 | $18M | 234k | 76.64 | |
Cardinal Health (CAH) | 5.2 | $17M | 335k | 51.49 | |
Spdr Gold Tr Gold Shs (GLD) | 4.6 | $15M | 90k | 170.96 | |
Galapagos Nv Spon Adr (GLPG) | 4.3 | $14M | 261k | 55.13 | |
McKesson Corporation (MCK) | 4.3 | $14M | 57k | 248.56 | |
AmerisourceBergen (COR) | 3.9 | $13M | 97k | 132.89 | |
United Therapeutics Corporation (UTHR) | 3.5 | $12M | 53k | 216.08 | |
Centene Corporation (CNC) | 3.1 | $10M | 126k | 82.40 | |
Herbalife Nutrition Com Shs (HLF) | 3.0 | $9.9M | 241k | 40.93 | |
Ionis Pharmaceuticals (IONS) | 3.0 | $9.8M | 323k | 30.43 | |
Aveanna Healthcare Hldgs (AVAH) | 2.1 | $7.1M | 958k | 7.40 | |
Integer Hldgs (ITGR) | 2.0 | $6.7M | 78k | 85.59 | |
Renovacor | 1.7 | $5.7M | 736k | 7.70 | |
Organon & Co Common Stock (OGN) | 1.6 | $5.4M | 178k | 30.45 | |
Pardes Biosciences | 1.5 | $5.1M | 312k | 16.37 | |
Albireo Pharma | 1.5 | $5.0M | 214k | 23.29 | |
Isoplexis Corp | 1.4 | $4.5M | 495k | 9.19 | |
Sanofi Sa Sponsored Adr (SNY) | 1.3 | $4.4M | 88k | 50.10 | |
Mirum Pharmaceuticals (MIRM) | 1.3 | $4.3M | 270k | 15.95 | |
Arena Pharmaceuticals Com New | 1.2 | $3.9M | 42k | 92.95 | |
Vapotherm | 1.1 | $3.7M | 180k | 20.71 | |
Kezar Life Sciences (KZR) | 1.1 | $3.6M | 213k | 16.72 | |
Oyster Point Pharma | 1.0 | $3.3M | 182k | 18.26 | |
Bicycle Therapeutics Sponsored Ads (BCYC) | 1.0 | $3.3M | 54k | 60.87 | |
Horizon Therapeutics SHS | 1.0 | $3.2M | 29k | 107.75 | |
Viking Therapeutics (VKTX) | 0.9 | $3.0M | 661k | 4.60 | |
Inogen (INGN) | 0.9 | $3.0M | 88k | 34.00 | |
Syros Pharmaceuticals | 0.9 | $2.9M | 901k | 3.26 | |
Merus N V (MRUS) | 0.9 | $2.9M | 90k | 31.80 | |
Natus Medical | 0.8 | $2.6M | 108k | 23.73 | |
Neubase Therapeutics Ord | 0.8 | $2.5M | 906k | 2.81 | |
Health Sciences Acquisitions Corp 2 Ord Shs | 0.8 | $2.5M | 250k | 10.08 | |
Eucrates Biomedical Acquisition Corp. Unit 10/23/2027 | 0.7 | $2.5M | 249k | 9.98 | |
Amedisys (AMED) | 0.7 | $2.4M | 15k | 161.87 | |
Rigel Pharmaceuticals Com New | 0.7 | $2.4M | 914k | 2.65 | |
Aeglea Biotherapeutics | 0.7 | $2.4M | 499k | 4.75 | |
Point Biopharma Global | 0.6 | $2.1M | 378k | 5.60 | |
Sierra Oncology Com New | 0.6 | $2.1M | 96k | 21.74 | |
Moleculin Biotech | 0.6 | $1.9M | 1.0M | 1.86 | |
Precision Biosciences Ord | 0.6 | $1.9M | 257k | 7.40 | |
Cymabay Therapeutics | 0.6 | $1.9M | 562k | 3.38 | |
Biosante Pharmaceuticals (ANIP) | 0.6 | $1.8M | 40k | 46.08 | |
Cyclacel Pharmaceuticals | 0.5 | $1.6M | 423k | 3.89 | |
Elevation Oncology (ELEV) | 0.5 | $1.5M | 250k | 6.02 | |
Bellus Health Com New Put Option | 0.4 | $1.5M | 182k | 8.05 | |
Leap Therapeutics | 0.4 | $1.4M | 440k | 3.24 | |
Aslan Pharmaceuticals Ads | 0.4 | $1.4M | 1.3M | 1.12 | |
Neogen Corporation Put Option (NEOG) | 0.3 | $1.1M | 25k | 45.42 | |
Mei Pharma Com New | 0.3 | $1.1M | 426k | 2.67 | |
Ardelyx (ARDX) | 0.3 | $1.1M | 995k | 1.10 | |
Fusion Pharmaceuticals | 0.3 | $1.1M | 260k | 4.17 | |
Vincerx Pharma Com New (VINC) | 0.3 | $1.0M | 102k | 10.19 | |
Savara (SVRA) | 0.2 | $807k | 651k | 1.24 | |
Nextcure (NXTC) | 0.2 | $780k | 130k | 6.00 | |
Ayala Pharmaceuticals Incorporated | 0.2 | $680k | 80k | 8.50 | |
Salarius Pharmaceuticals Com New | 0.2 | $671k | 1.4M | 0.50 | |
X4 Pharmaceuticals (XFOR) | 0.2 | $634k | 277k | 2.29 | |
Logicbio Therapeutics | 0.1 | $422k | 183k | 2.31 | |
Nyxoah Sa SHS (NYXH) | 0.1 | $371k | 16k | 23.03 | |
Renovacor *w Exp 99/99/999 | 0.1 | $240k | 400k | 0.60 | |
Caremax Com Cl A | 0.1 | $236k | 31k | 7.68 | |
Neoleukin Therapeutics | 0.1 | $185k | 38k | 4.83 | |
Universal Health Services CL B (UHS) | 0.0 | $161k | 1.2k | 129.53 | |
Mesoblast Spons Adr | 0.0 | $128k | 27k | 4.80 | |
Humacyte *w Exp 09/21/202 (HUMAW) | 0.0 | $114k | 50k | 2.28 | |
Caremax *w Exp 06/08/2026 (CMAXW) | 0.0 | $20k | 13k | 1.56 |